Free Trial

Amphastar Pharmaceuticals (AMPH) SEC Filings & 10K Form

Amphastar Pharmaceuticals logo
$30.62 +0.36 (+1.19%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$30.64 +0.02 (+0.08%)
As of 08/29/2025 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amphastar Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/12/2025
5:10 AM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
3:43 PM
Amphastar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025
6:17 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
4:30 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:19 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:04 PM
Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
6:45 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
6:02 PM
Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
5:30 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
5:39 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
5:40 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
3:23 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
7:27 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
3:07 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/14/2025
3:11 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/14/2025
3:18 PM
Amphastar Pharmaceuticals (Filer)
Form ARS
04/02/2025
5:45 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:43 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:13 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:38 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:41 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:53 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:14 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:16 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
5:10 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:29 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:00 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:33 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
6:21 PM
Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
Form SCHEDULE 13G/A
12/16/2024
4:22 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:28 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
10:37 AM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:26 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
7:05 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
6:02 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:09 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
6:48 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:48 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
08/30/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMPH) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners